Tramadol versus methadone for the management of acute opioid withdrawal: An add-on study

Journal of Research in Medical Sciences

Volumn 11, Issue 3, 2006, Pages 185-189

  Salehi, Mehrdad ^a,b   Amanatkar, M ^a   Barekatain, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Methadone; Opioid withdrawal; Tramadol

Indexed keywords

CLONIDINE; METHADONE; OPIATE; OXAZEPAM; PLACEBO; TRAMADOL;

ADD ON THERAPY; ADULT; AGITATION; ANALYSIS OF VARIANCE; ANXIETY; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DYSPHORIA; HEART PALPITATION; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; RECEPTOR AFFINITY; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SWEATING; WITHDRAWAL SYNDROME;

EID: 33748420516     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hafezi M, Asaadi SM, Razzaghi OM, Mokri A. High Doses of Buprenorphin in One day Opium Detoxification. Andishesh Va Raftar 2005; 10:196-202.
2. Kaplan and Sadock's Comprehension Textbook of Psychiatry. 8 ed. Philadelphia: Lippincott William & Wilkins, 2004.
3. Farrell M. Opiate withdrawal. Addiction 1994; 89:1471-1475.
4. Dayer P, Desmeules J, Collart L. [Pharmacology of tramadol]. Drugs 1997; 53 Suppl 2:18-24.
5. Lee CR, McTavish D, Sorkin EM. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993; 46:313-340.
6. Rojas-Corrales MO, Berrocoso E, Mico JA. Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol. Eur J Pharmacol 2005; 511:21-26.
7. Hopwood SE, Owesson CA, Callado LF, McLaughlin DP, Stamford JA. Effects of chronic tramadol on pre- and post-synaptic measures of monoamine function. J Psychopharmacol 2001; 15:147-153.
8. Ogata J, Minami K, Uezono Y, Okamoto T, Shiraishi M, Shigematsu A et al. The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes. Anesth Analg 2004; 98:1401-6, table.
9. Arcioni R, Della RM, Romano S, Romano R, Pietropaoli P, Gasparetto A. Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. Anesth Analg 2002; 94:1553-7, table.
10. Shiraishi M, Minami K, Uezono Y, Yanagihara N, Shigematsu A, Shibuya I. Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and in Xenopus oocytes expressing alpha 7 receptors. Br J Pharmacol 2002; 136:207-216.
11. Shiga Y, Minami K, Shiraishi M, Uezono Y, Murasaki O, Kaibara M et al. The inhibitory effects of tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M(3) receptors. Anesth Analg 2002; 95:1269-73, table.
12. Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth Analg 2005; 100:1400-5, table.
13. Sacerdote P, Bianchi M, Manfredi B, Panerai AE. Effects of tramadol on immune responses and nociceptive thresholds in mice. Pain 1997; 72:325-330.
14. Sobey PW, Parran TV, Jr., Grey SF, Adelman CL, Yu J. The use of tramadol for acute heroin withdrawal: a comparison to clonidine. J Addict Dis 2003; 22:13-25.
15. Threlkeld M, Parran TV, Adelman CA, Grey SF, Yu J. Tramadol versus Buprenorphine for the Management of Acute Heroin Withdrawal: A Retrospective Matched Cohort Controlled Study. Am J Addict 2006; 15:186-191.
16. Leo RJ, Narendran R, DeGuiseppe B. Methadone detoxification of tramadol dependence. J Subst Abuse Treat 2000; 19:297-299.
17. Gossop M. The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav 1990; 15:487-490.
18. Gowing L, Ali R, White J. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database Syst Rev 2002;CD002021.
19. Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust 1999; 171:26-30.
20. Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987; 13:293-308.
21. Tamaskar R, Parran TV, Jr., Heggi A, Brateanu A, Rabb M, Yu J. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study. J Addict Dis 2003; 22:5-12.